- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
62 Cards in this Set
- Front
- Back
|
Colonscopy Screening
|
Once every 10 years in patients over 50 years of age
or 40 years or greater for patients w/ high risk of patients CT virtual colonoscopy is comparable and can be used every five years as an initial screening exam |
|
Flexible sigmoidoscopy
|
once every five years in patients 50 or older
or 40 or older of age for high-risk patient |
|
FOBT or FIT
|
Once every year in patients 50 years of age or greater
or 40 years of age or greater in high risk patients |
|
Bimanual pelvic exam
|
Once every 1-3 years in patients 20-40 years of ae
Once yearly in patients 40 years of age or greater |
|
Pap test
|
once every year within 3 years after onset of vaginal intercourse, but no later than 21 up to age 30
once every two years w/ liquid based Pap test Interval can be increased to once every 2-3 years for women > 30 years of age w/ three - cytology tests |
|
Mammography
|
Once every 1-2 years in patients 40 you or older
Once yearly in patients 50 years of age or greater |
|
DRE
|
Offer every year to high-risk patients at 40 years and to others at 50 years
|
|
PSA
|
Offer every year to high-risk patients at 40 years adn to others at 50 years of age
|
|
Clinical breast exam
|
Offers every three years to female patients in 20s and 30s, and every year to females 40 or more years of age
|
|
Sensitivity
|
true positive / (true positive / false negative)
|
|
Specificity
|
true negative / (true negative + false positive)
|
|
Positive predictive value
|
probability that someone + truly has disease
TP/(TP + FP) |
|
Negative predictive value
|
probability that someone - truly does not have disease
TN/(TN + FN) |
|
likelihood ratio
|
how much more likely a given test result is in disease sate as opposed to non-disease state
|
|
+ LR
|
(diseased people w/ + result) / (nondiseased people w/ + result)
|
|
- LR
|
(diseased people w/ - result) / (nondiseased people w/ - result)
|
|
Cohort study
|
prospective study that provides incidence (new cases)
uses relative risk |
|
Case Control Study
|
Retrospective study that provides prevalence (total cases)
uses odds ratio |
|
Cross Sectional Study
|
Provides prevalence "snapshot"
|
|
Case report
|
describes unusalpatient
|
|
What is a Case Series Report
|
Describes several unusual patients
|
|
Consensus Panels
|
Panel of experts provides a recommendation
|
|
Meta-analysis
|
tries to combine data from many trials
|
|
Absolute risk
|
incidence of disease
|
|
Attributable risk
|
incidence of disease due to risky exposure, on top of background incidence from other causes
e.g., (number of injuries among staff who used scissors) - (number of injuries among staff who did not use scissors) |
|
Relative Risk
|
(incidence in exposed) / (incidence in unexposed)
|
|
Odds ratio
|
estimate of relative risk that is used in case-control studies
(odds that a diseased person is exposed) / (odds that a nondiseased is exposed) |
|
95% Confidence Interval
|
95% sure it lies within the interval
|
|
Number needed to treat
|
number needed to treat to change one life
|
|
p < 0.5
|
random chance that you will be wrong 1 out of 20 times
|
|
Null hypothesis
|
nothing's happening
|
|
Power
|
power of detecting a true intervention
|
|
type I error
|
P value error, false negative
"too optimistic" |
|
type II negative
|
Power error, false positive
"too positive" |
|
Accuracy
|
validity / truth
|
|
Precision
|
reliability
|
|
Selection bias
|
sample selected from other groups in additional determinants of outcome
e.g., surgeon picks patients w/o comorbidity for study |
|
Measurement bias
|
data-gathering methods differ btw groups
|
|
Confounding bias
|
third variable associated w/ both the dependent variable and independnet variable, idnucing false positive (type I bias)
|
|
Recall bias
|
difference btw two groups in retrospective recall of past factors or outcomes
e.g., patient w/ cancer more motivated to recall past episodes of exposure than healthy person |
|
Lead time bias
|
earlier detection of disease, gives appearance of prolonged survival, when natural course not actually altered
|
|
Length bias
|
screening detects disproportionate # of slowly progressive diseases, but misses rapidly progressive ones, overestimating the benefit of the screen
|
|
if confidence interval is high, power is
|
low
|
|
primary prevention
|
measures to decrease incidence of disease
|
|
secondary prevention
|
identifying disease early, when asymptomatic or mild, and implementing measures that can halt or slow disease progression
|
|
tertiary prevention
|
measures that decrease morbidity and mortality, resulting from presence of disease
|
|
Hepatitis B vaccine
|
birth
1 month 6 month |
|
DTaP
|
2 months
4 months 6 months 18 months 4-6 years 11-12 y: TdaP |
|
Hib
|
2 months
4 months 6 months 12 months |
|
IPV
|
2 months
4 months 6 months 4-6 yrs |
|
MMR
|
12 months
4-6 years |
|
Varicella
|
12 months
4-6 years |
|
Pneumococcal
|
2 mo
4 mo 6 mo 12 mo 65 yo |
|
Meningococcal
|
11-12 yo
|
|
Hep A
|
12 mo
18 mo |
|
Flu vaccine
|
6 mo
1 year then annually |
|
Hepatitis B vaccine
|
birth
1 month 6 month |
|
DTaP
|
2 months
4 months 6 months 18 months 4-6 years 11-12 y: TdaP |
|
Hib
|
2 months
4 months 6 months 12 months |
|
IPV
|
2 months
4 months 6 months 4-6 yrs |
|
MMR
|
12 months
4-6 years |
|
Rota virus
|
2 mo
4 mo 6 mo |